Prodrugs

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1989 Nov 1

PMID 2686738

Citations 6

Authors

D G Waller

C F George

Affiliations

Soon will be listed here.

Citing Articles

Novel Prodrug Strategies for the Treatment of Tuberculosis.

Kim C, Jose J, Hay M, Choi P Chem Asian J. 2024; 19(23):e202400944.

PMID: 39179514 PMC: 11613820. DOI: 10.1002/asia.202400944.

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.

Correll C, Kim E, Sliwa J, Hamm W, Gopal S, Mathews M CNS Drugs. 2021; 35(1):39-59.

PMID: 33507525 PMC: 7873121. DOI: 10.1007/s40263-020-00779-5.

Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology.

Autio K, Boni V, Humphrey R, Naing A Clin Cancer Res. 2019; 26(5):984-989.

PMID: 31601568 PMC: 8436251. DOI: 10.1158/1078-0432.CCR-19-1457.

Anhydride prodrugs for nonsteroidal anti-inflammatory drugs.

Shaaya O, Magora A, Sheskin T, Kumar N, Domb A Pharm Res. 2003; 20(2):205-11.

PMID: 12636158 DOI: 10.1023/a:1022214919481.

Prodrugs for the improvement of drug absorption via different routes of administration.

Balant L, Doelker E, Buri P Eur J Drug Metab Pharmacokinet. 1990; 15(2):143-53.

PMID: 2200683 DOI: 10.1007/BF03190197.

References

Albert A . Chemical aspects of selective toxicity. Nature. 1958; 182(4633):421-2. DOI: 10.1038/182421a0. View

Palfreyman M, McDONALD I, Fozard J, Mely Y, Sleight A, Zreika M . Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase. J Neurochem. 1985; 45(6):1850-60. DOI: 10.1111/j.1471-4159.1985.tb10543.x. View

Leigh D, Reeves D, Simmons K, Thomas A, Wilkinson P . Talampicillin: a new derivative of ampicillin. Br Med J. 1976; 1(6022):1378-80. PMC: 1640101. DOI: 10.1136/bmj.1.6022.1378. View

Rozencweig M, STAQUET M, Klastersky J . Antibacterial activity and pharmacokinetics of bacampicillin and ampicillin. Clin Pharmacol Ther. 1976; 19(5 Pt 1):592-7. DOI: 10.1002/cpt1976195part1592. View

Dreyfuss J, Shaw J, ROSS Jr J . Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs. J Pharm Sci. 1976; 65(9):1310-5. DOI: 10.1002/jps.2600650912. View

DUGGAN D, Hare L, Ditzler C, LEI B, Kwan K . The disposition of sulindac. Clin Pharmacol Ther. 1977; 21(3):326-35. DOI: 10.1002/cpt1977213326. View

ELION G, Furman P, Fyfe J, de Miranda P, Beauchamp L, Schaeffer H . Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977; 74(12):5716-20. PMC: 431864. DOI: 10.1073/pnas.74.12.5716. View

Krieglstein G, LEYDHECKER W . The dose-response relationships of dipivalyl epinephrine in open-angle glaucoma. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978; 205(3):141-6. DOI: 10.1007/BF00414393. View

Wilk S, Mizoguchi H, Orlowski M . gamma-Glutamyl dopa: a kidney-specific dopamine precursor. J Pharmacol Exp Ther. 1978; 206(1):227-32. View

10.

Fyfe J, Keller P, Furman P, Miller R, ELION G . Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol Chem. 1978; 253(24):8721-7. View

11.

Van Lear G, CHICCARELLI F, Bonenfant P, Barr A . Quantitation of the anti-inflammatory agent fenbufen and its metabolites in human serum and urine using high-pressure liquid chromatography. J Pharm Sci. 1978; 67(12):1662-4. DOI: 10.1002/jps.2600671206. View

12.

DUGGAN D, Hooke K, NOLL R, HUCKER H, VAN ARMAN C . Comparative disposition of sulindac and metabolites in five species. Biochem Pharmacol. 1978; 27(19):2311-20. DOI: 10.1016/0006-2952(78)90137-5. View

13.

Buchanan M, Rosenfeld J, Hirsh J . The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo. Thromb Res. 1978; 13(5):883-92. DOI: 10.1016/0049-3848(78)90193-7. View

14.

Welling P, Elliott R, Pitterle M, Lyons L . Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate. J Pharm Sci. 1979; 68(2):150-5. DOI: 10.1002/jps.2600680208. View

15.

ANDERSON J . Systemic absorption of topical ocularly applied epinephrine and dipivefrin. Arch Ophthalmol. 1980; 98(2):350-3. DOI: 10.1001/archopht.1980.01020030346024. View

16.

Ehrnebo M, Nilsson S, BOREUS L . Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in man. J Pharmacokinet Biopharm. 1979; 7(5):429-51. DOI: 10.1007/BF01062386. View

17.

Rainsford K, Whitehouse M . Are all aspirins really alike? A comparison of gastric ulcerogenicity with bio-efficacy in rats. Pharmacol Res Commun. 1980; 12(1):85-95. DOI: 10.1016/s0031-6989(80)80066-x. View

18.

PATCHETT A, Harris E, Tristram E, Wyvratt M, Wu M, Taub D . A new class of angiotensin-converting enzyme inhibitors. Nature. 1980; 288(5788):280-3. DOI: 10.1038/288280a0. View

19.

Pay G, Wallis R, Zelaschi D . A metabolite of sulphinpyrazone that is largely responsible for the effect of the drug on the platelet prostaglandin pathway. Biochem Soc Trans. 1980; 8(6):727-8. DOI: 10.1042/bst0080727. View

20.

Smith R, Dupe R, English P, Green J . Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature. 1981; 290(5806):505-8. DOI: 10.1038/290505a0. View